BRWM
TPST icon

B. Riley Wealth Management’s Tempest Therapeutics TPST Stock Holding History

B. Riley Wealth Management’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Hold
0
– -$28K – 691
2015
Q2 		– Hold
0
– – – 543
2014
Q4 		– Sell
-1
Closed -$31K – 1090
2014
Q3 		$31K Hold
1
– – 0.02% 513
2014
Q2 		$17K Hold
1
– – 0.01% 701
2014
Q1 		$17K Buy
+1
New +$28.3K 0.01% 663

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OH
Orbis Holdings Hamilton, Bermuda $12.8B AUM 8.29% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

B. Riley Wealth Management's TPST Position: Q3 2015 in Review

B. Riley Wealth Management held its Tempest Therapeutics (TPST) position steady in Q3 2015 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #691.

B. Riley Wealth Management first reported a position in TPST in Q1 2014 and has held it in 3 quarters since. The position peaked at $31K in Q3 2014. 90 funds tracked by Wall St. Rank hold TPST as of Q3 2015.

  • B. Riley Wealth Management held 0 shares of Tempest Therapeutics worth $0 as of Q3 2015.
  • B. Riley Wealth Management left its Tempest Therapeutics share count unchanged in Q3 2015.
  • Tempest Therapeutics made up ﹤0.01% of B. Riley Wealth Management's portfolio in Q3 2015, its #691 holding.
  • B. Riley Wealth Management first reported a position in Tempest Therapeutics in Q1 2014 and has held it in 3 quarters since.
  • B. Riley Wealth Management's Tempest Therapeutics position peaked at $31K in Q3 2014.
  • 90 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2015.

Based on B. Riley Wealth Management's 13F filing for Q3 2015, filed 13 Oct 2015.